Eye drops promise clearer vision for a treatment approved following clinical trials demonstrating improvements in near vision ...
Ocular Therapeutix's AXPAXLI met FDA-approved primary endpoint in Phase 3 trial, outperforming Eylea by 18% in vision preservation at week 36.
Half of the world's vision loss could have been prevented – the WHO explains why 2.2 billion people are affected and how to reduce your risk. | Health ...
Ever since I was a child, squiggly lines and dots have always been present in my field of vision.When I look at them, ...
This week, the companies announced wins across their late-stage Clarity-1 and Clarity-2 studies of once-daily brepocitinib in ...
<?xml encoding="utf-8" ?> Roivant Sciences Ltd. ROIV and its subsidiary Priovant Therapeutics announced positive results Wednesday from two Phase 3 trials evaluating brepocitinib for noninfectious ...
Brepocitinib 45 mg once-daily achieved statistically significant benefit compared to placebo on the primary and all key secondary endpoints for each of CLARITY-1 and CLARITY-2, the two identical Phase ...
High myopia is not just a high prescription. In many cases, it involves structural changes in the eye that affect the retina ...
Arwyp Medical Centre partnered with ophthalmologist Dr Priscilla Mokhethe to provide free eye screenings to 20 people, ...
Q: I use an over-the-counter eye drop several times a day to soothe my dry, itchy eyes. Is that OK? If your eyes are often ...
We break down the first FDA-approved myopia treatment glasses, candidate eligibility for kids, and daily wear expectations.
Suddenly, there was a piece of lint in front of my eyes...What is this?At first, I thought maybe some dust had gotten on my ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results